According to the Wall Street Journal, the silver lining of an imminent resurgence in U.S. IPOs has disappeared. Ticket marketplace StubHub and fintech firm Klarna have postponed their IPO roadshow, which was originally scheduled to begin next week, according to people familiar with the matter. Chime, another fintech firm, is delaying its public financial filing with regulators and has also delayed its IPO, some of these people said. Virtual physical therapy firm Hinge Health is keeping an eye on the market and is expected to list by the end of April, the people said. Cryptocurrency firm Circle is close to the next step of going public, but is now anxiously waiting to see before deciding what to do. Also, there have been reports of medline delaying its U.S. IPO. The stock market plunge on Thursday and Friday closed the door for companies waiting to go public. The US IPO market has endured a rough patch over the past three years, but many bankers and lawyers hope 2025 will be the year IPOs return to a normal pace. Instead, the global trade war is roiling equities, rattling investors and executives alike.